BPA Call 75F40120A00018-75F40123F19024

Award Date 6/1/23
Potential Completion Date 9/30/24
Potential Value $155K
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services Food and Drug Administration awarded Westat, Inc. a $85,413.18 firm fixed price blanket purchase agreement call contract to provide quick turnaround surveys. The contract was awarded against Westat's Advertising & Integrated Marketing Solutions GSA schedule and will be performed in Silver Spring, Maryland through September 2025. No subcontractors or set aside designations were identified. The contract supports FDA's mission to protect public health...
The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price contract valued at $149,898 to Westat, Inc. to provide quick turnaround social science research services. This award draws from Westat's existing Advertising & Integrated Marketing Solutions GSA schedule contract vehicle to fulfill a request for quick turnaround study support. No set-aside designation was applied. Westat will perform the work in Potomac, Maryland, leveraging its expertise...
The Department of Health and Human Services Food and Drug Administration awarded a task order worth $531,215 to Westat, Inc. under the agency's Quick Turnaround Social Science Research Services Blanket Purchase Agreement call. The task order is titled "General Population Survey on Prescription Drug Promotion" and requires the contractor to conduct a survey to gather information from the general population on prescription drug promotion. Work will be performed in Potomac, Maryland...
Westat, Inc. was awarded a $480,469 firm fixed price task order under the Department of Health and Human Services Food and Drug Administration's (HHS FDA) Quick Turnaround Social Science Research Services blanket purchase agreement (BPA). The task order is for perceptions of efficacy and adherence research relating to FDA-regulated products under development and postmarket surveillance. As the prime contractor, Westat will conduct the social science research services at its place of...
The Department of Health and Human Services Food and Drug Administration awarded Westat, Inc. a $241,826.67 firm fixed price blanket purchase agreement call under the Advertising & Integrated Marketing Solutions (AIMS) Government-wide Acquisition Contract. The purpose of this award is to support the Pregnancy and Lactation Labeling Rule by conducting health care provider testing to improve health communications related to lactation. Westat will deliver quick turnaround services for the FDA...
This is a firm fixed-price delivery order contract awarded by the Food and Drug Administration (FDA) to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract, valued at $169,624.00, is for a project titled "UNDERSTANDING THE USE OF PRESCRIBING INFORMATION IN THE HEALTH CARE SYSTEM" and is part of a larger indefinite delivery, indefinite quantity (IDIQ) contract called "CDER Priority Analysis". The contract has no set-aside designation. Westat...
This is a firm fixed-price BPA call awarded by the Food and Drug Administration (FDA) to Westat, Inc., a professional services firm based in Rockville, Maryland. The contract is for a "Quantitative Terms and Phrases Study" to be conducted under the FDA's Quick Turnaround Social Science Research Services Blanket Purchase Agreement (BPA). The contract has a ceiling value of $399,533.00 and a period of performance that runs through August 1, 2025. Westat has significant experience...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $729,939 firm fixed price task order contract to Westat, Inc. under the Advertising & Integrated Marketing Solutions (AIMS) Government-Wide Acquisition Contract (GWAC) master contract. Westat will provide Food Safety and Nutrition Survey services for HHS FDA from their Berwyn Heights, Maryland location between August 5th, 2022 and August 15th, 2025. No applicable subcontractors were identified.
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to Westat, Inc., a provider of professional services to government agencies. The contract, which has a potential value of $447,205.00, is a Blanket Purchase Agreement (BPA) Call under the Advertising & Integrated Marketing Solutions (AIMS) GSA Schedule. The contract is for "Endorser Status and Explicitness of Payment in Direct-to-Consumer Promotion" and is categorized under...
This is a task order awarded by the Food and Drug Administration (FDA) to Westat, Inc., a professional services firm based in Rockville, Maryland. The task order is titled "Experimental Study of Risk Information Amount and Location in Direct-to-Consumer" and was issued under the Advertising & Integrated Marketing Solutions (AIMS) Blanket Purchase Agreement (BPA) contract vehicle. The task order has a firm fixed-price ceiling value of $798,027.00 and was awarded on June 12, 2016,...

The Department of Health and Human Services Food and Drug Administration awarded Westat, Inc. a $154,730 firm fixed price blanket purchase agreement call under its Advertising & Integrated Marketing Solutions multiple award schedule contract. The purpose of this award is to provide quick turnaround social science research services to support FDA's prescription drug promotion in electronic health records initiative through conducting healthcare provider interviews. As the prime contractor, Westat will deliver the requested market research and data collection services from its Potomac, Maryland location over a one year and three month period ending in September 2024. No set aside designation was specified. The award is expected to generate insights for FDA to better understand how electronic health records are currently used to promote prescription drugs and help shape the agency's policies in this area.

Generated 12/30/23, 7:06 PM